News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Xcellerex, Inc. Signs Memorandum of Understanding with SK Chemicals Co. Ltd. to Commercialize SK-Developed Vaccines with FlexFactory(R) Platform


8/26/2010 8:33:04 AM

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Xcellerex, Inc. announced today that it has signed a memorandum of understanding with SK Chemicals, Co., Ltd., one of South Korea’s largest industrial groups, for an alliance to develop and commercialize SK-developed vaccines with Xcellerex’s FlexFactory® biomanufacturing platform. The companies expect to define specific terms of the alliance in the coming months.

Read at BioSpace.com

comments powered by Disqus
   
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES